does tirzepatide cause birth defects Increased Risk of NICU Stays for Babies Born to Mothers Prescribed GLP-1 Medications in the 90 Days Before Pregnancy Are Ozempic and Mounjaro safe

Zepbound demonstrated 20.9% mean body weight reduction in SURMOUNT-1 at 15mg surpassing semaglutides 15% benchmark and establishing dual GIP/GLP-1 agonism as the dominant next-generation obesity mechanism

You should not take Tirzepatide 25mg if: You are diagnosed with type 1 diabetes or diabetic ketoacidosis

The ultimate goal is to be able to get back to enjoying life as soon as possible

Smaller, more frequent intake: both food and fluids: tends to sit better and reduces nausea compared to trying to eat normal-sized meals less often

doi:10.1016/s0140-6736(23)02750-2 Childhood obesity is a complex health issue

This program is geared towards educating patients on how to effectively use the medication, manage their condition, and establish healthier lifestyles